BTXA Nanotherapy Ltd

Website Back to portfolio

BXTA Nanotherapy Ltd is an innovative biotech company advancing the development and commercialisation of nanotherapeutics to improve treatment outcomes for patients with cancer.

Background: Radiotherapy is the primary treatment modality for several cancers including prostate cancer where approximately 50% of men are treated with curative intent. However, around 20-30% of men (~3,500 per year in UK) with intermediate- to high-risk disease experience treatment failure. Additionally, radiotherapy can also result in damage to neighbouring healthy tissue including the bladder and bowel, severely impacting patient quality of life.

 Technology: Gold nanoparticles act as potent radiosensitisers, making tumour cells more susceptible to the killing effects of radiotherapy. By enhancing radiation dose in the localised vicinity of the nanoparticle, they limit the potential for additional damage to the surrounding normal and healthy tissue. 

BXTA Nanotherapy Ltd was founded in 2023 as a joint venture between BXTAccelyon Ltd (BXTA) and QUBIS, with the primary aim of advancing the development, regulatory approval, and commercialisation of our lead nanoparticle formulation termed AuX2R. This innovative nanotherapeutic combines the physical effects of gold with propriety molecular targeting to enhance tumour cell sensitivity to radiotherapy. AuX2R has undergone substantial pre-clinical development and is positioned to enter clinical investigation.

Visit website
  • Aflo - Respiratory Analytics Ltd

    Automating correct inhaler technique in asthma & COPD with the aflo platform
    Eradicating technique errors, improving symptom control and reducing the carbon footprint of Metered Dose Inhalers.

    Read more
  • engineering

    Acksen Ltd

    Manufacture of electronic dataloggers.

    Read more
  • engineering, digital

    Analytics Engines Ltd

    At Analytics Engines, we see data differently. Our expert team delivers creative, agile data solutions, which are as unique as the challenges they solve.

    Read more
  • digital

    AdoreBoard Ltd

    Adoreboard is an emotion AI company that unites customer and employee experience through its Human Experience measurement platform Emotics to understand how people really feel.

    Read more

Our use of cookies

Some cookies are necessary for us to manage how our website behaves while other optional, or non-necessary, cookies help us to analyse website usage. You can Accept All or Reject All optional cookies or control individual cookie types below.

You can read more in our Cookie Notice

Functional

These cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

Analytical cookies help us to improve our website by collecting and reporting information on its usage.

Third-Party Cookies

These cookies are set by a website other than the website you are visiting usually as a result of some embedded content such as a video, a social media share or a like button or a contact map